Why should American headache and migraine patients still be treated with butalbital-containing medicine?

Peer Carsten Tfelt-Hansen, Hans-Christoph Diener

11 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Headache
Vol/bind	52
Udgave nummer	4
Sider (fra-til)	672-4
Antal sider	3
ISSN	0017-8748
DOI	https://doi.org/10.1111/j.1526-4610.2012.02115.x
Status	Udgivet - 2012

Adgang til dokumentet

10.1111/j.1526-4610.2012.02115.x

Citationsformater

@article{2c690996f3d14cb7b2b5fe404a3899c5,

title = "Why should American headache and migraine patients still be treated with butalbital-containing medicine?",

author = "Tfelt-Hansen, {Peer Carsten} and Hans-Christoph Diener",

year = "2012",

doi = "10.1111/j.1526-4610.2012.02115.x",

language = "English",

volume = "52",

pages = "672--4",

journal = "Headache",

issn = "0017-8748",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Why should American headache and migraine patients still be treated with butalbital-containing medicine?

AU - Tfelt-Hansen, Peer Carsten

AU - Diener, Hans-Christoph

PY - 2012

Y1 - 2012

U2 - 10.1111/j.1526-4610.2012.02115.x

DO - 10.1111/j.1526-4610.2012.02115.x

M3 - Journal article

C2 - 22404123

SN - 0017-8748

VL - 52

SP - 672

EP - 674

JO - Headache

JF - Headache

IS - 4

ER -